Altimmune (ALT) Tax Rate (2012 - 2025)
Altimmune (ALT) reported Tax Rate of 3.36% for Q1 2025, up 304.68% quarter-over-quarter from 0.83% in Q3 2022.
Altimmune (ALT) Tax Rate (2012 - 2025) Analysis & Trends
Altimmune (ALT) has 11 years of Tax Rate data on file, last reported at 3.36% in Q1 2025.
- Tax Rate for Q1 2025 came in at 3.36%, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was 19.31% (changed N/A YoY), and the FY2025 annual result was 19.31%, changed N/A from the prior year.
- Tax Rate improved to 3.36% in Q1 2025 per ALT's latest filing, from 0.83% in the prior quarter.
- Over five years, Tax Rate peaked at 3.36% in Q1 2025 and troughed at 0.83% in Q3 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -57.14 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -6.79 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 5.61 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 17.68 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Altimmune | 336.67 Mn | 336.67 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 3.36% |
| Mar 31, 2025 | 3.36% |
| Sep 30, 2022 | 0.83% |
| Sep 30, 2022 | 0.83% |
| Dec 31, 2020 | 1.03% |
| Dec 31, 2020 | 1.03% |
| Sep 30, 2020 | 2.64% |
| Sep 30, 2020 | 2.64% |
| Jun 30, 2020 | 8.61% |
| Jun 30, 2020 | 8.61% |
| Mar 31, 2020 | 45.51% |
| Mar 31, 2020 | 45.51% |
| Sep 30, 2019 | 0.53% |
| Sep 30, 2019 | 0.53% |
| Dec 31, 2018 | -11.14% |
| Dec 31, 2018 | -11.14% |
| Sep 30, 2018 | 26.08% |
| Sep 30, 2018 | 26.08% |
| Jun 30, 2018 | 14.08% |
| Jun 30, 2018 | 14.08% |